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Abstract 25 
Background: Chronic spinal cord injury (SCI) increases morbidity and mortality associated 26 
with cardiometabolic diseases, secondary to increases in central adiposity, hyperlipidemia and 27 
impaired glucose tolerance. While upper-body moderate intensity continuous training (MICT) 28 
improves cardiorespiratory fitness, its effects on cardiometabolic component risks in adults 29 
with SCI appears relatively modest. The aim of this study is to assess the acute effects of Circuit 30 
Resistance Training (CRT), High Intensity Interval Training (HIIT), MICT and rest (CON) on 31 
fasting and postprandial systemic biomarkers and substrate utilisation. Methods: Ten healthy 32 
chronic SCI (>1 year, ASIA A-C) males will be recruited. Following preliminary testing, each 33 
will complete four experimental conditions, where they will report to the laboratory following 34 
a ~10 hour overnight fast. A venous blood sample will be drawn and expired gases collected 35 
to estimate resting metabolic rate (RMR).  In order to ensure an isocaloric exercise challenge, 36 
each will complete CRT first, with the remaining three conditions presented in randomised 37 
order: i) CRT, ~45 min of resistance maneuvers (weight lifting) interspersed with low-38 
resistance, high-speed arm crank exercise; ii) CON, seated rest; iii) MICT, ~45 min constant 39 
arm crank exercise at a resistance equivalent to 30-40% peak power output (PPO) and; iv) 40 
HIIT, ~35 min arm crank exercise with the resistance alternating every 2 min between 10% 41 
PPO and 70% PPO. After each ~45 min condition, participants will ingest a 2510 kJ liquid test 42 
meal (35% Fat, 50% CHO, 15% Protein). Venous blood and expired gas samples will be 43 
collected at the end of exercise and at regular intervals for 120 min post-meal. Discussion: 44 
This study will establish the acute effects of different forms of exercise on fasting and 45 
postprandial responses in chronic SCI males. Measures of glucose clearance, insulin 46 
sensitivity, lipid and inflammatory biomarker concentrations will be assessed and changes in 47 
whole body substrate oxidation estimated from expired gases. Trial registration: Trial 48 
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retrospectively registered with ClinicalTrials.gov under registration number NCT03545867 on 49 
1 June 2018. 50 
Key words: exercise, spinal cord injury, upper body exercise, continuous resistance training, 51 
high-intensity interval training, postprandial, metabolism. 52 
 53 
Background 54 
Chronic spinal cord injury (SCI) increases morbidity and mortality associated with 55 
cardiovascular [1] and metabolic diseases [2]. These clinical outcomes are preceded by a higher 56 
prevalence of known risk factors including central adiposity [3], hyperlipidemia [4] and 57 
impaired glucose tolerance [5]. These elevated risks are not restricted to persons with SCI, but 58 
also effect the broader disabled population. Persons with a range of physical disabilities 59 
demonstrate a 1.2 to 3.9-fold higher prevalence of obesity than those without a physical 60 
disability [6]. It seems intuitive to suggest that this elevated prevalence of cardiometabolic 61 
component risks is, at least in part, associated with the Disability-Associated Low Energy 62 
Expenditure Deconditioning Syndrome (DALEEDS), first described by Rimmer et al. [7]. 63 
 64 
Therapeutic Benefits of Exercise Training 65 
Traditional forms of moderate intensity continuous training (MICT) can provide some 66 
therapeutic benefits and reduce some components of cardiometabolic risk in persons with SCI 67 
[8]. Sixteen weeks of upper-body MICT, with minimal resistance training, reduces total body 68 
fat mass and visceral adipose tissue content in persons with SCI [9]. While just 6-weeks of 69 
MICT can also enhance fasting markers of hepatic insulin sensitivity in persons with 70 
paraplegia, the effects on post-prandial markers of peripheral insulin sensitivity are negligible 71 
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[10]. Indeed, neither of these training studies were able to demonstrate a significant benefit of 72 
MICT on cardiometabolic components related to post-prandial insulin sensitivity, 73 
hyperlipidaemia or systemic inflammation. This has led to a call for high quality randomised 74 
controlled trials to assess the efficacy of higher intensity forms of exercise and assess the acute 75 
post-exercise responses in systemic biomarkers and energy homeostasis and to novel exercise 76 
challenges [11]. Currently, relatively little is known about the acute regulation of energy 77 
homeostasis at rest, during, or post-exercise in the SCI population. 78 
 79 
Acute Metabolic Responses to Exercise in SCI 80 
When compared to non-injured controls performing voluntary leg exercise, persons with SCI 81 
have markedly reduced mobilisation, delivery, and limb uptake of free fatty acids (FFA) during 82 
electrically-stimulated leg exercise [12]. This is most likely the result of reduced 83 
sympathoadrenal ß-adrenergic stimulation and/or limited neural activity in motor centers and 84 
afferent nerves from contracting skeletal muscles, depending on the level of injury [12]. The 85 
limited availability of FFA during exercise leads to a heavy reliance on carbohydrate (CHO), 86 
with a concomitant limited contribution from fat as a fuel source [13-14]. These observations 87 
appear consistent across a variety of modes and intensities of exercise [15-16]. Increased 88 
reliance on carbohydrate as a fuel source during exercise may effect the metabolic handling of 89 
systemic glucose and lipids, both during and post-exercise. 90 
 91 
Energy Expenditure in Persons with SCI 92 
In non-injured individuals, human energy expenditure (EE) is elevated during recovery from 93 
exercise [17]. These increases in EE occur in a dose-dependent manner, which is predominantly 94 
related to exercise intensity and modality, as opposed to exercise duration [17]. Only three 95 
studies have compared changes in EE following isocaloric arm and leg cycling in non-injured 96 
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humans and have demonstrated only modest increases in post-exercise EE in response to arm 97 
cycling [18-20]. Arm cycling resulted in a lower cumulative post-exercise EE compared to 98 
isocaloric leg cycling [19], suggesting that upper extremity exercise per se has a limited ability 99 
to elevate post-exercise EE. Only one study has examined these responses to arm cycling in 100 
persons with SCI [21], demonstrating only a modest increase in post-exercise EE, which was 101 
similar to that observed in non-injured humans. This may reflect a reduced ability of the upper 102 
body skeletal muscles to tolerate sustained anaerobic metabolism and accumulate oxygen debt. 103 
However, it remains to be determined if exercise mode and/or intensity have the ability to 104 
modulate post-exercise EE in persons with SCI. 105 
 106 
Substrate Metabolism in Persons with SCI 107 
Associated with the increases in EE at rest, both CHO [22] and fat oxidation rates [23-25] are 108 
significantly increased during recovery from exercise. This effect of exercise on substrate 109 
partitioning occurs in a manner dependent more on the total energy cost of exercise and less on 110 
exercise intensity or metabolic rate [23]. While the increase in post-exercise fat oxidation has 111 
been demonstrated in non-injured humans [20], to date, no studies have examined this response 112 
in persons with SCI. Our pilot data [26] demonstrate that fat oxidation is elevated for at least 113 
120 min following ~50 min of circuit resistance training (CRT) in persons with SCI. 114 
 115 
Postprandial Responses in Persons with SCI 116 
Several studies in persons with SCI have reported exaggerated post-prandial lipaemia (PPL) 117 
[27-28] and glycemia (PPG) [29], which is of some concern, as such chronically elevated 118 
responses are component risks for cardiometabolic disease [30]. In persons without SCI, a 119 
juxta-meal exercise bout has a dramatic effect on the metabolic handling and disposal of 120 
macronutrients from a meal. Specific to CHO and fat disposal, pre-meal exercise attenuates 121 
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PPL [25] and PPG [22] even in persons with known disorders of energy homeostasis [22, 29]. 122 
Interestingly, both exercise modality [17, 24] and intensity [17, 31] have been shown to modify 123 
the effect of exercise on post-exercise energy homeostasis, independently of exercise-related 124 
EE. However, to our knowledge, no studies have examined the acute effects of different forms 125 
of exercise on post-prandial systemic metabolite, hormone, or biomarker concentrations or 126 
whole-body substrate oxidation rates in persons with SCI. 127 
 128 
Objectives 129 
In summary, it is currently unknown whether, in persons with SCI, the mode or intensity of 130 
pre-meal exercise influences the metabolic handling and oxidation of macronutrients. The 131 
objectives of the proposed study are therefore to compare the effects of resting Control (CON), 132 
Moderate Intensity Continuous Training (MICT), High Intensity Interval Training (HIIT) and 133 
Circuit Resistance Training (CRT) on: 134 
1) Fasting systemic concentrations of metabolites, hormones and relevant inflammatory 135 
biomarkers. 136 
2) Post-prandial systemic concentrations of metabolites, hormones and relevant 137 
inflammatory biomarkers. 138 
3) Post-prandial EE and whole-body substrate oxidation rates. 139 
The central hypothesis is that higher intensity intermittent upper-body exercise (i.e. HIIT and 140 
CRT) will enhance measures of fasting and post-prandial insulin sensitivity, compared to 141 
moderate intensity exercise (MICT) or rest (CON). 142 
 143 
 144 
 145 
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Methods/Design 146 
Study Design 147 
This study is a partially randomised repeated measures counter-balanced crossover design. 148 
Participants will attend two preliminary sessions including baseline assessments and a HIIT 149 
familiarisation session before completing the four experimental conditions. Each participant 150 
will complete the CRT condition first in order that the intensity and/or duration of the HIIT 151 
and MICT protocols can be adjusted to deliver an isocaloric exercise challenge. The CON, 152 
MICT and HIIT conditions will be completed in a randomised order, at least 3 days apart. 153 
The planned experimental design is summarised below (Figure 1) and is consistent with 154 
current Standardised Protocol Items: Recommendations for Interventional Trials (SPIRIT) 155 
guidelines [32-33]. The study protocol has been approved by the Human Subjects Research 156 
Office, Miller School of Medicine, University of Miami (Institutional Review Board No. 157 
20171114, Version 3, dated 5 February 2018) and the trial has been registered as a current 158 
controlled trial (ClinicalTrials.gov Registration Number NCT03545867 on 1 June 2018).  159 
 160 
[INSERT FIGURE 1 ABOUT HERE] 161 
 162 
Study setting 163 
All human testing will take place in the Lois Pope Life Center at the Miami Project to Cure 164 
Paralysis at the University of Miami’s Miller School of Medicine. All biochemical analyses 165 
will take place at the Diabetes Research Institute, Division of Endocrinology, Diabetes and 166 
Metabolism at the University of Miami Miller School of Medicine. 167 
 168 
 169 
 170 
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Recruitment 171 
It has been reported that participant recruitment to research studies, especially in the absence 172 
of direct access to a clinical population, requires considerably more resources and time than 173 
initially anticipated in order to achieve adequate enrollment [34]. Patient barriers are reported 174 
to include [35]: (1) additional demands of the trial increasing participant burden and (2) 175 
patient preferences for or against a particular treatment. Barriers to research participation are 176 
perhaps even more exaggerated for people with disabilities due to complex health problems 177 
[36], lack of transportation [37], cognitive impairments and financial stress [38]. 178 
 179 
In order to overcome some of these barriers and challenges, The Miami Project maintains and 180 
supports the running of a clinical exercise programme, where individuals with SCI that have 181 
volunteered to participate in a Miami Project study, can access a fully-equipped gymnasium 182 
free-of-charge. Associated with this, a user database is maintained, containing basic 183 
descriptive information on persons with SCI who have volunteered to participate in previous 184 
studies and volunteered ongoing participation. Upon initial contact with individuals from this 185 
user community (i.e. email or telephone), the study will be described and those interested in 186 
enrolling will be asked to read a detailed participant information sheet and complete a health 187 
screening questionnaire. Interested individuals will be screened via a telephone conversation 188 
48 h after their initial contact to ascertain eligibility. A focus will be placed on establishing a 189 
good rapport at this initial contact and also as participant’s progress through the enrollment 190 
process (Figure 1). Written consent will be obtained during the initial laboratory visit and 191 
participants will be informed that they can withdraw from the study at any time without 192 
consequence. Participants will be paid for their participation in this study, following 193 
completion of all assessments. This is primarily designed to reimburse travel expenses and 194 
thank them for any inconvenience caused. 195 
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Randomisation 196 
After completion of baseline laboratory testing, the HIIT familiarisation and the CRT 197 
condition, participants will complete the remaining three experimental conditions in random 198 
order. Randomisation will be performed by an independent senior researcher (MN) using a 199 
list generated with a web-based platform (www.randomization.com), concealed from those 200 
involved in participant management (DM, JM and JB) to prevent biased allocation [39-40]. 201 
 202 
Participants 203 
To address our hypothesis, a cohort of 10 healthy males with chronic spinal cord injury, who 204 
satisfy the inclusion and exclusion criteria outlined below, will be recruited via advertisement 205 
and direct contact with the local SCI community. 206 
 207 
Inclusion Criteria: 1) Male; 2) Aged ≥ 18 years old; 3) Neurologically stable spinal cord 208 
injury (ASIA Impairment Scale A-C) at T6 and lower spinal levels for > 1 year; 4) Able and 209 
willing to comply with study procedures; 5) Have the ability to understand written and 210 
spoken English; 6) Have the capacity to provide informed consent. 211 
 212 
Exclusion Criteria: 1) Female; 2) < 18 years old; 3) Contraindication to exercise (ACSM 213 
Guideline, 10th edition); 4) Lower extremity fracture or dislocation within 6 months of 214 
participation; 5) History head injury or seizures; 6) Inability to provide informed consent; 7) 215 
Restrictions in upper extremity range of motion that would prevent an individual from 216 
achieving an unhindered arm cycling motion or moving throughout a range needed to perform 217 
resistance maneuvers; 8) Had a pressure ulcer at ischial/gluteus, trochanteric, sacral, or heel 218 
sites within the last 3 months; 9) Imprisonment in state or federal jail or prison; 10) Taking any 219 
medication that might interfere with the study outcomes (this will be reviewed by the research 220 
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team on a case-by-case basis should a potential participant be on regular medication. The 221 
British National Formulary will be checked for potential effects that might introduce bias in 222 
the study); 11) Illness/condition that might interact with study measures (e.g. diabetes, heart 223 
disease) or pose undue personal risk. 224 
 225 
Preliminary Assessments 226 
 227 
General 228 
Participants’ cardiorespiratory fitness and muscular strength will be assessed using the 229 
procedures outlined below. Their descriptive characteristics (i.e. age, body mass) and basic 230 
injury characteristics will be recorded via self-report questionnaire. Following these 231 
assessments, the participants will schedule their remaining laboratory test days (outlined 232 
below). They will be instructed on how to record their normal daily diet on a “food log” that 233 
will be completed the day prior to the first main trial (i.e. CRT). Before each of the following 234 
three trial days, participants will be provided with (1) a copy of their original food log and (2) 235 
a blank food log, and will be asked to reproduce this dietary intake to the best of their abilities, 236 
but to record on the new food log their actual dietary intake. 237 
 238 
Arm Cycle Ergometry (ACE) Cardiorespiratory Fitness Testing 239 
Cardiorespiratory fitness (V̇O2 peak) will be assessed during a graded exercise test (GXT). 240 
Participants will refrain from exercise/alcohol/caffeine for 24 h prior to testing and perform a 241 
continuous GXT on an electrically braked arm crank ergometer (Lode Angio, Groningen, 242 
Netherlands) at a constant cadence of 60 +/- 5 rpm. A digital display will provide real-time 243 
feedback on cadence. Every 3 min, resistance will increase by 20 Watts (W). Participants will 244 
continue until volitional exhaustion manifesting as either a non-verbal communication of the 245 
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desire to stop or an inability to maintain cadence above 55 rpm. Upon cessation, participants 246 
will rest quietly for 10 min. Prior to each test, a staff member will interview the participant to 247 
determine the individualised wattage starting work rate and increments to target a V̇O2 peak 248 
(i.e., volitional exhaustion) within 9-15 min. Starting loads will range from 0 to 50 W, with 249 
smaller loads for sedentary individuals. This approach is consistent with the American College 250 
of Sports Medicine’s Guidelines for Exercise Testing and Prescription (10th edition) 251 
recommendation that starting loads and increments be individualised to the participant’s 252 
perceived functional capacity [41]. Expired gases will be continuously collected in a Hans-253 
Rudolph Softmask worn by the participant and analysed by a portable open-circuit indirect 254 
calorimetry system (Oxycon Mobile, Viasys, Inc). 255 
 256 
One-Repetition Maximum (1RM) Muscular Strength Testing 257 
To determine the resistance levels assigned for the CRT trial, upper extremity dynamic strength 258 
testing will be performed on a Helms equalizer 1000 multi-station exerciser (Helm 259 
Distributing, Polson, MT) using the following maneuvers: overhead press, horizontal row, 260 
vertical butterfly, biceps curl, latissimus pull down (either to the chest or neck) and dips. 261 
Participants will be instructed to perform eight repetitions of each maneuver, with each 262 
repetition lasting six seconds (3 seconds concentric, 3 seconds eccentric). If eight repetitions 263 
are completed in controlled fashion, the weight will be increased and the exercise repeated. 264 
Incremental increases in weight will be provided until eight controlled repetitions cannot be 265 
completed. The 1-repetition maximum (1-RM) will be calculated using previously published 266 
equations [42]: 267 
 268 
1-RM = WT/ (0.533 + 0.419E -0.055*REPS)        (1) 269 
 270 
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Where ‘1-RM’ is the calculated one repetition maximum strength, ‘WT’ is the resistance used in the 271 
last set where more than three, but fewer than eight repetitions are completed, and ‘REPS’ equals the 272 
number of repetitions completed in the last set of testing. 273 
 274 
HIIT Familiarisation 275 
 276 
During their second preliminary visit to the laboratory, participants will be fitted with a Hans-277 
Rudolph Softmask and expired gases will be collected and analysed throughout exercise (as 278 
described above). Participants will conduct ~50 min of arm crank ergometry (ACE) on the 279 
same device/position as described above during the GXT. The cycle ergometer will be 280 
programmed to vary power output so that a warm-up and cool-down (2 min) and the active 281 
recovery intervals will be completed at 10% peak power output (POpeak), and the working 282 
intervals completed at 70% POpeak. The ratio of work:recovery intervals will be 1:1. The EE 283 
data will later be used to calculate the duration of HIIT required to elicit an isocaloric challenge 284 
to CRT. 285 
 286 
Main Trials 287 
 288 
The same experimental procedures will be completed on all four main trial days (Figure 1). These 289 
procedures are also reflected in the Standardised Protocol Items: Recommendations for 290 
Interventional Trials (SPIRIT) figure (Figure 2). Twenty-four hours prior to each main laboratory 291 
trial, participants will abstain from caffeine (tea/coffee) and alcohol. On the morning of the main trials, 292 
participants will be instructed to consume ~10 ml.kg-1 of water on waking and report to the laboratory 293 
at 0800 ± 0.5 h following an overnight fast (≥ 10 h). Following entry to the laboratory participants will 294 
be fitted with the mask for indirect calorimetry (as described above) and will remain seated prone in 295 
their wheelchair for ~10 min to assess resting EE (REE). Immediately after this, an initial 10 ml venous 296 
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blood sample will be drawn. For the next ~50 min, expired gases and heart rate will continue to be 297 
collected while the participants rest (CON) or exercise (MICT, HIIT or CRT). Immediately after this 298 
period, an indwelling cannula will be inserted in to an antecubital vein and kept patent with sterile 299 
saline. An initial sample will be drawn before participants consume a 600 kcal liquid meal test meal 300 
(35% Fat, 50% CHO, 15% Protein). Further 10 ml venous blood samples will be drawn at 0, 15, 30, 60, 301 
90, and 120 min post-meal. Expired gases will continue to be collected throughout the post-prandial 302 
period. 303 
 304 
Resting Control (CON) 305 
During the resting control (CON) condition, participants will remain seated in a prone position 306 
for 50 min. If they require the bathroom during this period, they will be pushed to and from the 307 
room and the time recorded. 308 
 309 
[INSERT FIGURE 2 ABOUT HERE] 310 
 311 
Moderate Intensity Continuous Training (MICT) 312 
Following baseline measurements, participants will conduct ~50 min of ACE on the same 313 
device/position as described above during the same electronically braked ergometer (Figure 314 
3a). The cycle ergometer will be programmed to provide a constant predetermined resistance 315 
equivalent to ~60% of the POpeak achieved during the GXT. The exact duration of the MICT 316 
trial will be calculated to deliver an isocaloric challenge that is equivalent to the CRT trial. 317 
 318 
High Intensity Interval Training (HIIT) 319 
Following baseline measurements, participants will conduct ~50 min of ACE on the same 320 
electronically braked ergometer (Figure 3a). The cycle ergometer will be programmed to vary 321 
the resistance to produce a power output for the warm-up, cool-down (2.5 min) and active 322 
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recovery intervals equivalent to 10% POpeak, and the working intervals completed at 70% 323 
POpeak. The ratio of work:recovery intervals will be 1:1 and HIIT will continue until an 324 
estimated (from the HIIT familiarisation trial) a total EE equivalent to the CRT condition is 325 
achieved. 326 
 327 
Circuit Resistance Training (CRT) 328 
Following baseline measurements, participants will conduct ~50 min of CRT consisting of 329 
resistance maneuvers (weight lifting) and low-resistance, high-speed endurance activities 330 
(arm cranking). The efficacy of the CRT for delivering fitness and health related benefits for 331 
persons with paraplegia, have been described previously [43-45] and recently adopted by the 332 
Paralyzed Veterans of America and endorsed by the member organizations of the American 333 
Spinal Injuries Association [46]. Participants will perform 10 repetitions of lifting on each of 334 
the following exercise stations: (1) military press (Figure 3b), (2) horizontal rows (Figure 3c), 335 
(3) pectoralis ("pec") dec (Figure 3d), (4) preacher curls (elbow flexion) (Figure 3e), (5) wide 336 
grip latissimus pull-down (Figure 3f), and (6) seated dips (Figure 3g). All maneuvers will be 337 
conducted at 60 %1RM as determined during strength testing. Every time participants 338 
complete two resistance exercises they will perform low-resistance, high-speed arm exercise 339 
for two minutes on a stationary cycle. They will rest 10 seconds between each set of 340 
repetitions, and will complete three cycles of the exercises. Our previous data indicate that 341 
CRT will elicit a mean exercise EE of ~170 kcal in persons with paraplegia [26]. However, 342 
the individual variability is large (SD = 55 kcal), primarily dependent on the resistance set for 343 
each activity and, hence the need to conduct CRT before the other exercise interventions. 344 
 345 
[INSERT FIGURE 3 ABOUT HERE] 346 
 347 
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Emergencies and Adverse Events 348 
 349 
Participants will be monitored for the following both during and after treatments: headaches, 350 
pain, lightheadedness, dizziness, altered vision, respiratory distress, cyanosis, spasms, or 351 
change in function.  We will also monitor cardiovascular responses to treatment to ensure that 352 
participants do not exceed lower (< 40 bpm) and upper (> 180 bpm) limits for heart rate or 353 
systolic blood pressure (i.e. < 85 mm Hg and > 200 mm Hg). 354 
 355 
The skin located near pressure points will be inspected after every exercise session. Exercise 356 
trials will be stopped if the participants experience any of the following: chest pain, dyspnea, 357 
diaphoresis, or pale or ashen appearance. All testing is being performed at a medical centre 358 
and is therefore located near an emergency room. Security personnel at the Miami Project are 359 
all trained “first responders”. The lab has approved policies and procedures for emergencies 360 
and all staff have current certification for cardio-pulmonary resuscitation. 361 
 362 
All adverse events will be reported to the IRB within the mandated time period. For any 363 
adverse event the Principal Investigator will immediately notify and consult with the Study 364 
Physician, who will come to an opinion as to whether the event(s) is related to the study 365 
procedures described in the protocol. Adverse events will be evaluated by the Study 366 
Physician using the following criteria: 367 
i) Grade 1 (Mild): Awareness of symptoms, but easily tolerated; usually transient requiring 368 
no special treatment; does not interfere with usual or normal daily activities. 369 
ii) Grade 2 (Moderate):  May be ameliorated by simple therapeutic measures; may interfere 370 
with, but not keep the participant from participating in normal daily activities. 371 
iii) Grade 3: Incapacitating event, inability to perform usual activities. 372 
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iv) Grade 4, (Life-threatening/Disabling):  Patient is at risk of death, or worsening disability 373 
or impairment as existed at the time of the event. 374 
 375 
For the first two grades the Investigators will observe the participant and as necessary 376 
institute standard medical or therapeutic care. Repeated occurrence of Grade 1 and 2 events 377 
may be cause for notification of the IRB by the Investigators that stoppage is appropriate. The 378 
Investigators may take this action and the IRB will be so notified. Grade 3 and 4 events will 379 
be individually evaluated. Any occurrence of Grade 3 and 4 events may be cause for 380 
notification of the IRB by the Investigators that stoppage is appropriate. The investigators 381 
may take this action and the IRB will be so notified. Otherwise, upon on an IRB 382 
determination that the (S)AE was related to the protocol, the study will stop and undergo 383 
evaluation for continuation. 384 
 385 
Experimental Measures 386 
 387 
Energy Expenditure 388 
Energy expenditure and substrate oxidation rates will be determined from expired gas 389 
analysis, at rest and during exercise, using indirect calorimetric methods. The following 390 
equations will be used [47]: 391 
 392 
Energy expenditure (kcal/min) = 3.941 ∙ ?̇?𝑂2 + 1.106 ∙ ?̇?𝐶𝑂2   (2) 393 
CHO-ox (g/min) = 4.344 ∙ ?̇?𝐶𝑂2 − 3.061 ∙ ?̇?𝑂2      (3) 394 
Fat-ox (g/min) = 1.695 ∙ ?̇?𝑂2 − 1.701 ∙ ?̇?𝐶𝑂2     (4) 395 
 396 
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Pre-exercise REE will be accepted as stable when repeated measurements are within 100 397 
kcal.day-1 [48, 49] and the lowest of these measures will be accepted as RMR [50]. 398 
 399 
Blood sampling 400 
Following the ~50 min rest or exercise sessions, a cannula (BD, VenflonTM Pro, Becton 401 
Dickenson & Co., Sweden) will be inserted into an antecubital vein from which repeated 10 402 
ml blood samples will be drawn, as previously described. Plasma samples will be centrifuged 403 
immediately at 3,466 g at 4°C for 10 min (Heraeus Biofuge Primo R, Kendro Laboratory 404 
Products Plc., Tyne and Wear, UK). Serum samples will be left to clot for 60 min at room 405 
temperature before centrifugation. All samples will be dispensed into 1.0 ml aliquots and 406 
stored at -80°C. 407 
 408 
Outcome Measures 409 
 410 
In order to simplify data analysis and facilitate the interpretation of a complex data set [51, 52], 411 
serial measurements of glucose and insulin responses at baseline, post-exercise, and in response 412 
to the rest/exercise challenge will be converted into simple summary statistics [53], such as 413 
incremental area under the curve (iAUC) [54] and insulin sensitivity index (ISIMatsuda) [55]. 414 
The Homeostasis Model Assessment (HOMA) calculator, incorporating the updated HOMA-415 
2 model [56], will be used to derive fasting estimates of pancreatic β -cell function, insulin 416 
resistance and sensitivity, both at rest and post-exercise. A full lipid profile (Triglycerides, total 417 
cholesterol, NEFA, HDL-C, LDL-C) will also be assessed to establish the influence of exercise 418 
protocol on post-exercise and post-prandial responses. From indirect calorimetric 419 
measurements, EE, fat and carbohydrate oxidation rates will be determined and compared, 420 
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primarily during the post-prandial phase. The primary and secondary outcome variables are 421 
presented in Table 1. 422 
 423 
[INSERT TABLE 1 ABOUT HERE] 424 
 425 
Data Storage and Availability 426 
 427 
Electronic Data Records 428 
All electronic files are stored on password-protected computers in rooms 1-48 and 1-50 of the 429 
Lois Pope Life Center. Computer security is provided by data encryption, firewall protection, 430 
and data backup on the Miami Project Server. Source data obtained from metabolic analysis 431 
will be entered into a de-identified data bank and stored securely on the network. 432 
 433 
Physical Data Records 434 
Data will be stored in a locked room (LPLC 1-50), in a locked file cabinet, which is only 435 
accessible to study personnel in the Lois Pope Life Center, 1095 NW 14th Terrace, Miami, FL 436 
33136. The metabolic analyser used to obtain data is located locked in a room (1-49) accessible 437 
by University ID badge after passing a security desk and a hallway accessed by proximity card. 438 
A security badge is needed to open the office door where the data are stored. A security guard 439 
is located in the front lobby, and the hallway to the storage site is secured by proximity card 440 
entry. 441 
 442 
Procedures to Release Data 443 
To maximize access to the final dataset, after publication of the analyses described within this 444 
protocol, we will deposit the final dataset in a to be determined data repository. Prior to deposit 445 
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in the repository, the final dataset will be anaonymised. Access to data and procedures to 446 
release the data will be defined by the policies of the repository in which the data are placed.  447 
 448 
Power Calculation 449 
We plan to recruit 10 male participants with chronic (>1 year) spinal cord injury (SCI), by 450 
engaging users from the Miami Project to Cure Paralysis community. The primary outcome 451 
variables are related to fasting and postprandial glycemic control, but specifically postprandial 452 
insulin area under curve (iAUC). While there are only two previous studies have compared the 453 
effects of MICT and HIIT on biomarkers of metabolic regulation in non-disabled humans [57, 454 
58], both suggest no effect of MICT (vs. CON) and an enhanced effect of HIIT. We therefore 455 
hypothesised that there will be no differences in postprandial glycemic control between CON 456 
and MICT and a similarly enhanced effect of HIIT and CRT. Using data from these previous 457 
studies, the mean predicted effect size is ~1. We therefore estimated that a final sample size of 458 
10 will be required for this repeated measures study, to provide approximately 90% power to 459 
detect a significant difference in ∆ insulin iAUC at an alpha level of 0.05. Recruitment will 460 
proceed on a rolling basis until the adequate sample size is reached; emphasis will be placed 461 
on considering the demands of the study before enrolling to reduce drop-out during the study. 462 
 463 
Statistical analysis 464 
All data from participants that successfully complete the study will be included in the analysis. 465 
The differences in key outcome variables between experimental conditions (CON, MICT, CRT 466 
and HIIT) and time (dependent on variable) will be analysed using a two-way (condition × 467 
time) fully repeated measures analysis of variance (ANOVA). Where significant interactions 468 
are observed, multiple t-tests will determine the location of variance. Significant post-hoc 469 
effects will be subjected to a Holm-Bonferroni stepwise adjustment. Standardised effect sizes 470 
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(Cohen’s d) will also be calculated. This will provide a practical interpretation of the size of 471 
the effects of each experimental condition relative to CON. For all the above statistical 472 
approaches, statistical significance will be set at an alpha level of p ≤ 0.05. We will explore the 473 
use of confidence intervals and magnitude-based inferences to assess the clinical significance 474 
of the effect. 475 
Discussion 476 
Previous research suggests that higher intensity exercise, resulting in greater skeletal muscle 477 
glycogen depletion within an individual session, are likely necessary to enhance biomarkers of 478 
cardiometabolic component risk, particularly peripheral insulin sensitivity [43, 57-58]. This 479 
may be particularly true in humans that have lost the ability to innervate a large proportion of 480 
their skeletal muscle mass, such as persons with SCI. Such conditions create numerous barriers 481 
to physical activity engagement and the need to maximise the potential metabolic benefits of 482 
individual bouts of physical activity becomes paramount. This has led to a recent call for high 483 
quality randomised controlled trials to assess the efficacy of higher intensity exercise protocols 484 
on cardiometabolic component risks in persons with SCI [11]. However, before engaging in 485 
such complex intervention studies, it is important to understand the acute physiological and 486 
metabolic responses to a single bout of different forms of upper-body exercise in this 487 
population. 488 
 489 
To our knowledge, this study will be the first to compare the acute metabolic responses of 490 
persons with SCI to two novel higher intensity modes of upper-body exercise (CRT and HIIT) 491 
with a more traditional form of exercise (MICT) and rest (CON). While the two forms of higher 492 
intensity exercise are quite different in nature, they both include intermittent exposures to 493 
higher intensity metabolic activity, which is likely to lead to a relatively greater level of muscle 494 
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glycogen depletion than MICT [59]. As muscle glycogen concentration is an important driver 495 
of acute changes in peripheral insulin sensitivity following exercise, this presents a very 496 
plausible mechanism for at least an acute up-regulation of glycemic regulation [60-62]. This 497 
approach will help elucidate the exercise modalities and associated mechanisms, which will 498 
likely provide the greatest therapeutic stimulus for enhanced physiological function and 499 
metabolic regulation in a population with a high prevalence of cardiometabolic disease. 500 
 501 
Trial status 502 
Institutional Review Board Protocol No. 20171114, Version 3, dated 5 February 2018. 503 
Recruitment start date: 1 March 2018. Recruitment end date: 4 February 2018. 504 
 505 
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 507 
ACE  Arm crank ergometry 508 
ASIA  American Spinal Injuries Association 509 
CHO  Carbohydrate 510 
CON  Resting control condition 511 
CRT  Circuit Resistance Training 512 
CRIT  Continuous, Resistance or High Intensity Interval Training study 513 
DALEEDS Disability-Associated Low Energy Expenditure Deconditioning Syndrome 514 
FFA  Free Fatty Acids 515 
GXT  Graded exercise test 516 
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PPG  Post-prandial glycemia 520 
PPL  Post-prandial lipaemia 521 
PPO  Peak power output 522 
REE  Resting energy expenditure 523 
RMR  Resting Metabolic Rate 524 
SCI  Spinal Cord Injury 525 
V̇O2 peak Peak oxygen uptake 526 
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 759 
Table 1. Primary and Secondary Outcome Variables. 760 
Outcome Measure Analytical Method 
Metabolites 
 Glucose 
 
 Lipids 
 
Plasma glucose concentration will be assessed using an automated analyser (Randox RX Daytona, Co. 
Antrim, UK). 
Serum markers of total triglycerides, total cholesterol, NEFA, HDL-C and LDL-C will also be assessed 
using an automated analyser and commercially available immunoassays (Randox Laboratories, Co. Antrim, 
UK). 
Hormones 
 Insulin 
 
Determined using ELISA (Mercodia AB, Uppsala, Sweden). Variables: 
i) incremental area under the curve (iAUC) [54]; 
ii)  insulin sensitivity index (ISIMatsuda ) [55]; 
iii)  Homeostasis Model Assessment (HOMA-2 model [56] 
Inflammatory Markers 
 Il-6 
 
Baseline and post-exercise measures of IL-6 will be assessed using ELISA (Quantikine HS, R&D systems 
Inc., Abingdon, UK) 
Energy Expenditure 
 Total Energy Expenditure 
(kcal/min) 
 CHO-ox (g/min) 
 Fat-ox (g/min) 
 
Total energy expenditure and substrate oxidation rates will be determined from expired gas analysis, at rest 
and during exercise, using indirect calorimetric methods, as previously described [47]. 
 761 
 762 
30 
 
Figure 1. Study flow diagram demonstrating the order of recruitment, testing and main trial procedures. 763 
764 
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Figure 2. Standardised Protocol Items: Recommendations for Interventional Trials (SPIRIT) 765 
figure. 766 
 767 
768 
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Figure 3. Images of a single participant completing the various elements of the exercise testing regime: a) arm crank ergometry; b) military 769 
press; c) horizontal row; d) pectoralis ("pec") dec; e) preacher curl; f) wide grip latissimus pull-down and; g) seated dip. 770 
 771 
